Skip to content

Sunday, June 29, 2025

Latest:

A culturally sensitive approach for pediatricians to navigate co-sleeping conversations with families
Baylor recognizes faculty excellence in research with DeBakey Awards
What you need to know about sickle cell disease
From a terrifying diagnosis to training for a marathon: Abigail’s miracle story
Researchers uncover rare gene variants contributing to systemic sclerosis risk

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

CAR T cell

Sprinter and marathoner CAR T cells reveal their distinct cancer-killing behavior

February 4, 2025 cancer treatment, CAR T cell, Research, solid tumors

The study lays a foundation for designing CAR molecules that maximize antitumor activity beyond B cell malignancies.

A potential new therapeutic target for Group 3 medulloblastoma

August 8, 2024 CAR T cell, grade3-medulloblastoma, Immunotherapy, pediatric brain cancer, protogenin, Research

Researchers identified and located a population of stem-like cells that initiates and maintains Group 3 medulloblastoma in the developing brain.

New insights into the mediators of patient recovery after CAR T cell immunotherapy

July 21, 2020 cancer therapy, CAR T cell, Clinical Trials, complete response, HER-2, Immunotherapy, Research, rhabdomyosarcoma

Clinical trial of novel personalized CAR T cell immunotherapy provides clues into what mediated exceptional patient recovery.

From the Labs: Image of the Month

From the Labs: a closer look at metastatic medulloblastoma

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951